Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong A

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Biomedicine & Biotechnology|April 10, 2010
Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68Ivaylo Gentschev, Ulrike Donat, Elisabeth Hofmann, et al.
Molecular Medicine (Cambridge, Mass.)|March 17, 2009
A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imagingNanhai Chen, Qian Zhang, Yong A Yu, et al.
Journal of Virological Methods|February 17, 2015
HA1-specific indirect ELISA for serological detection of canine influenza virus H3N2 infection in dogsDoo Hee Shim, Jeong-Ki Kim, Minki Hong, et al.
International Journal of Cancer|June 5, 2013
Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endotheliumLisa Buckel, Sunil J Advani, Alexa Frentzen, et al.
Annals of Surgical Oncology|January 20, 2012
A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancersDana Haddad, Nanhai Chen, Qian Zhang, et al.
Journal of Oncology|July 16, 2010
Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68Ivaylo Gentschev, Klaas Ehrig, Ulrike Donat, et al.
Bioengineered|October 25, 2012
Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapyIvaylo Gentschev, Sandeep S Patil, Marion Adelfinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2012
Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenograftsSunil J Advani, Lisa Buckel, Nanhai G Chen, et al.
The Journal of Surgical Research|February 21, 2012
Effective oncolytic vaccinia therapy for human sarcomasShuangba He, Pingdong Li, Chun-Hao Chen, et al.
Surgery|June 8, 2015
Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinomaJustin W Ady, Clark Johnsen, Kelly Mojica, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Biomedicine & Biotechnology|April 10, 2010
Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68Ivaylo Gentschev, Ulrike Donat, Elisabeth Hofmann, et al.
Molecular Medicine (Cambridge, Mass.)|March 17, 2009
A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imagingNanhai Chen, Qian Zhang, Yong A Yu, et al.
Journal of Virological Methods|February 17, 2015
HA1-specific indirect ELISA for serological detection of canine influenza virus H3N2 infection in dogsDoo Hee Shim, Jeong-Ki Kim, Minki Hong, et al.
International Journal of Cancer|June 5, 2013
Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endotheliumLisa Buckel, Sunil J Advani, Alexa Frentzen, et al.
Annals of Surgical Oncology|January 20, 2012
A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancersDana Haddad, Nanhai Chen, Qian Zhang, et al.
Journal of Oncology|July 16, 2010
Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68Ivaylo Gentschev, Klaas Ehrig, Ulrike Donat, et al.
Bioengineered|October 25, 2012
Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapyIvaylo Gentschev, Sandeep S Patil, Marion Adelfinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2012
Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenograftsSunil J Advani, Lisa Buckel, Nanhai G Chen, et al.
The Journal of Surgical Research|February 21, 2012
Effective oncolytic vaccinia therapy for human sarcomasShuangba He, Pingdong Li, Chun-Hao Chen, et al.
Surgery|June 8, 2015
Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinomaJustin W Ady, Clark Johnsen, Kelly Mojica, et al.
Pageof 7